Jeff Sacher

Jeff Sacher is the Chief Financial Officer (CFO) at Fore Biotherapeutics, where he brings extensive experience in corporate finance and investment banking. He has a proven track record of collaborating with boards and CEOs to build effective teams and drive financial strategies. His career includes significant roles at companies such as Viacell, Goldman Sachs, and Needham & Company, among others.

Sacher has raised over $5 billion in capital across various markets and has managed numerous transactions, including IPOs, mergers, and acquisitions. His expertise extends to negotiating business development deals and strategic partnerships within the biopharma and medical device sectors. He has also served in various executive roles, overseeing operations, finance, investor relations, and more.1

He holds an MBA with concentrations in Finance, Accounting, and Health Care Management from Northwestern University's Kellogg School of Management, and a Bachelor of Arts in Biology from Cornell University.1